Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Ana A. Giménez-Capitán"'
Autor:
Ana María Giménez Capitán, Pablo Rubisntein, Andrés Aguilar-Hernández, María González-cao, Irene Moya, Santiago Viteri, Carlos Cabrera, Santiago Ramón y Cajal, Karina Loor, Mario Culebras, Irene Sansano, Federico Rubisntein, Joselyn Valarezo, Clara Mayo-de las-Casas, Carlos Pedraz, Joseph Beechem, Sarah Warren, Rafael Rosell, Miguel Ángel Molina-Vila
Publikováno v:
Cancer Research. 82:1424-1424
Background: Non-small cell lung cancer (NSCLC) is usually diagnosed at stages IIIB-IV, with a median overall survival that does not exceed two years. In contrast, patients diagnosed at early and locally advanced stages (I-IIIA) can undergo surgery an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::61f652c93728d7ab54c37c3f03d957f2
https://doi.org/10.1158/1538-7445.am2022-1424
https://doi.org/10.1158/1538-7445.am2022-1424
Autor:
Ana A. Giménez-Capitán, Chung-Ying Huang, Jill Bracht, Rich Boykin, Clara Mayo-de-las-Casas, Joseph M. Beechem, Cristina Teixidó, Ariadna Balada-Bel, Beatriz Garcia, Sergio Villatoro, Monica Garzón, Nuria Jordana-Ariza, Cristina Aguado, Santiago Viteri, Juan José García, Rafael Rosell, Jay Gerlach, Noemi Reguart, Miguel Angel Molina-Vila
Publikováno v:
Cancer Research. 79:1384-1384
Background: With the advent of precision medicine, screening for clinically relevant mutations and gene fusions is mandatory in many tumor types. However, in a significant number of cancer patients, the tumor tissue available is insufficient for gene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::edc4492efff4c53f8a00993fe35c625b
https://doi.org/10.1158/1538-7445.am2019-1384
https://doi.org/10.1158/1538-7445.am2019-1384
Autor:
Rosell R; Germans Trias i Pujol Research Institute, Badalona (IGTP), Spain; IOR, Hospital Quiron-Dexeus, Barcelona, Spain. Electronic address: rrosell@iconcologia.net., Codony-Servat J; Pangaea Oncology, Hospital Quiron-Dexeus, Barcelona, Spain., González J; Germans Trias i Pujol Research Institute, Badalona (IGTP), Spain., Santarpia M; Medical Oncology Unit, Department of Human Pathology 'G. Barresi', University of Messina, Italy., Jain A; Department of Microbiology, JSS Academy of Higher Education & Research, Mysuru, India., Shivamallu C; Department of Biotechnology & Bioinformatics, JSS Academy of Higher Education & Research, Mysuru, Karnataka, India., Wang Y; Genfleet Therapeutics, Shanghai, China., Giménez-Capitán A; Pangaea Oncology, Hospital Quiron-Dexeus, Barcelona, Spain., Molina-Vila MA; Pangaea Oncology, Hospital Quiron-Dexeus, Barcelona, Spain., Nilsson J; Department Radiation Sciences, Oncology, Umeå University, Sweden., González-Cao M; IOR, Hospital Quiron-Dexeus, Barcelona, Spain.
Publikováno v:
Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2024 Mar; Vol. 195, pp. 104228. Date of Electronic Publication: 2023 Dec 09.
Autor:
García-Roman S; Laboratory of Oncology/Pangaea Oncology S.L., Dexeus University Hospital, C/ Sabino Arana 5, Barcelona 08023, Spain., Garzón-Ibáñez M; Laboratory of Oncology/Pangaea Oncology S.L., Dexeus University Hospital, C/ Sabino Arana 5, Barcelona 08023, Spain., Bertrán-Alamillo J; Laboratory of Oncology/Pangaea Oncology S.L., Dexeus University Hospital, C/ Sabino Arana 5, Barcelona 08023, Spain., Jordana-Ariza N; Laboratory of Oncology/Pangaea Oncology S.L., Dexeus University Hospital, C/ Sabino Arana 5, Barcelona 08023, Spain., Giménez-Capitán A; Laboratory of Oncology/Pangaea Oncology S.L., Dexeus University Hospital, C/ Sabino Arana 5, Barcelona 08023, Spain., García-Peláez B; Laboratory of Oncology/Pangaea Oncology S.L., Dexeus University Hospital, C/ Sabino Arana 5, Barcelona 08023, Spain., Vives-Usano M; Laboratory of Oncology/Pangaea Oncology S.L., Dexeus University Hospital, C/ Sabino Arana 5, Barcelona 08023, Spain., Codony-Servat J; Laboratory of Oncology/Pangaea Oncology S.L., Dexeus University Hospital, C/ Sabino Arana 5, Barcelona 08023, Spain., d'Hondt E; IN3BIO Europe ltd, Aberdeen, UK., Rosell R; Instituto Oncológico Dr. Rosell (IOR), Dexeus University Hospital, Barcelona, Spain; Catalan Institute of Oncology and Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Badalona, Spain., Molina-Vila MÁ; Laboratory of Oncology/Pangaea Oncology S.L., Dexeus University Hospital, C/ Sabino Arana 5, Barcelona 08023, Spain. Electronic address: mamolina@panoncology.com.
Publikováno v:
Translational oncology [Transl Oncol] 2024 Feb; Vol. 40, pp. 101878. Date of Electronic Publication: 2024 Jan 06.
Autor:
Pedraz-Valdunciel C; Pangaea Oncology, Dexeus University Hospital, Barcelona, Spain., Ito M; Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan., Giannoukakos S; Facultad de Ciencias, Universidad de Granada, Granada, Spain., Giménez-Capitán A; Pangaea Oncology, Dexeus University Hospital, Barcelona, Spain., Molina-Vila MÁ; Pangaea Oncology, Dexeus University Hospital, Barcelona, Spain., Rosell R; Pangaea Oncology, Dexeus University Hospital, Barcelona, Spain.; Germans Trias i Pujol Health Sciences Institute and Hospital (IGTP), Badalona, Spain.
Publikováno v:
JTO clinical and research reports [JTO Clin Res Rep] 2023 Nov 15; Vol. 4 (12), pp. 100604. Date of Electronic Publication: 2023 Nov 15 (Print Publication: 2023).
Autor:
Vergés C; Department of Ophthalmology, Hospital Universitari Dexeus, Area Oftalmológica Avanzada, Universitat Politécnica de Catalunya, Barcelona, Spain. Electronic address: cverges@cverges.com., Giménez-Capitán A; Pangaea Oncology, Laboratory of Oncology, Dexeus University Hospital, Barcelona, Spain., Ribas V; Department of Ophthalmology, Hospital Universitari Dexeus, Area Oftalmológica Avanzada, Universitat Politécnica de Catalunya, Barcelona, Spain., Salgado-Borges J; Department of Ophthalmology, Hospital Universitari Dexeus, Area Oftalmológica Avanzada, Universitat Politécnica de Catalunya, Barcelona, Spain., March de Ribot F; Department of Ophthalmology, Hospital Universitari Dexeus, Area Oftalmológica Avanzada, Universitat Politécnica de Catalunya, Barcelona, Spain., Mayo-de-Las-Casas C; Pangaea Oncology, Laboratory of Oncology, Dexeus University Hospital, Barcelona, Spain., Armiger-Borras N; Pangaea Oncology, Laboratory of Oncology, Dexeus University Hospital, Barcelona, Spain., Pedraz C; Pangaea Oncology, Laboratory of Oncology, Dexeus University Hospital, Barcelona, Spain., Molina-Vila MÁ; Pangaea Oncology, Laboratory of Oncology, Dexeus University Hospital, Barcelona, Spain.
Publikováno v:
The ocular surface [Ocul Surf] 2023 Oct; Vol. 30, pp. 42-50. Date of Electronic Publication: 2023 Jul 29.
Autor:
Giménez-Capitán A; Pangaea Oncology, Laboratory of Oncology, Dexeus University Hospital, Barcelona, Spain., Sánchez-Herrero E; Atrys Health, Barcelona, Spain.; Liquid Biopsy Laboratory, Biomedical Sciences Research Institute Puerta de Hierro-Majadahonda, Madrid, Spain., Robado de Lope L; Liquid Biopsy Laboratory, Biomedical Sciences Research Institute Puerta de Hierro-Majadahonda, Madrid, Spain., Aguilar-Hernández A; Dr Rosell Oncology Institute, Quirón Dexeus University Hospital, Barcelona, Spain., Sullivan I; Dr Rosell Oncology Institute, Quirón Dexeus University Hospital, Barcelona, Spain.; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Calvo V; Medical Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Spain., Moya-Horno I; Hospital Universitario General de Cataluña Grupo Quirón, Sant Cugat del Vallés, Spain., Viteri S; UOMI Cancer Center, Clínica Mi Tres Torres, Barcelona, Spain., Cabrera C; UOMI Cancer Center, Clínica Mi Tres Torres, Barcelona, Spain., Aguado C; Pangaea Oncology, Laboratory of Oncology, Dexeus University Hospital, Barcelona, Spain., Armiger N; Pangaea Oncology, Laboratory of Oncology, Dexeus University Hospital, Barcelona, Spain., Valarezo J; Pangaea Oncology, Laboratory of Oncology, Dexeus University Hospital, Barcelona, Spain., Mayo-de-Las-Casas C; Pangaea Oncology, Laboratory of Oncology, Dexeus University Hospital, Barcelona, Spain., Reguart N; Hospital Clínic de Barcelona, Spain., Rosell R; Dr Rosell Oncology Institute, Quirón Dexeus University Hospital, Barcelona, Spain.; Hospital Germans Trias i Pujol, Health Sciences Institute and Hospital (IGTP), Barcelona, Spain., Provencio M; Medical Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Spain., Romero A; Liquid Biopsy Laboratory, Biomedical Sciences Research Institute Puerta de Hierro-Majadahonda, Madrid, Spain.; Medical Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Spain., Molina-Vila MA; Pangaea Oncology, Laboratory of Oncology, Dexeus University Hospital, Barcelona, Spain.
Publikováno v:
Molecular oncology [Mol Oncol] 2023 Sep; Vol. 17 (9), pp. 1884-1897. Date of Electronic Publication: 2023 Jun 06.
Autor:
Bertran-Alamillo J; Laboratory of Oncology, Pangaea Oncology, Quiron Dexeus University Hospital, C/ Sabino Arana 5-19, 08913, Barcelona, Spain., Giménez-Capitán A; Laboratory of Oncology, Pangaea Oncology, Quiron Dexeus University Hospital, C/ Sabino Arana 5-19, 08913, Barcelona, Spain., Román R; Laboratory of Oncology, Pangaea Oncology, Quiron Dexeus University Hospital, C/ Sabino Arana 5-19, 08913, Barcelona, Spain., Talbot S; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, CB21 6GH, UK., Whiteley R; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, CB21 6GH, UK., Floc'h N; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, CB21 6GH, UK., Martínez-Pérez E; Bioinformatics Unit, Fundación Instituto Leloir, Buenos Aires, C1405BWE, Argentina., Martin MJ; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, CB21 6GH, UK., Smith PD; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, CB21 6GH, UK., Sullivan I; Servicio de Oncología Médica, Hospital de la Santa Creu i Sant Pau, Barcelona, 08025, Spain.; Instituto Oncológico Dr. Rosell, Hospital Universitario Dexeus, Barcelona, 08028, Spain., Terp MG; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense C, 5000, Denmark., Saeh J; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, MA, 02451, USA., Marino-Buslje C; Bioinformatics Unit, Fundación Instituto Leloir, Buenos Aires, C1405BWE, Argentina., Fabbri G; Translational Medicine, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, MA, 02451, USA., Guo G; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, MA, 02451, USA., Xu M; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, MA, 02451, USA., Tornador C; Teresa Moretó Foundation and Wholegenix SL, Barcelona, 08021, Spain., Aguilar-Hernández A; Instituto Oncológico Dr. Rosell, Hospital Universitario Dexeus, Barcelona, 08028, Spain., Reguart N; Thoracic Oncology Unit, Department of Medical Oncology, Hospital Clínic, Barcelona, 08036, Spain., Ditzel HJ; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense C, 5000, Denmark.; Department of Oncology, Odense University Hospital, Odense, 5000, Denmark., Martínez-Bueno A; Instituto Oncológico Dr. Rosell, Hospital Universitario Dexeus, Barcelona, 08028, Spain., Nabau-Moretó N; Teresa Moretó Foundation and Wholegenix SL, Barcelona, 08021, Spain., Gascó A; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Rosell R; Instituto Oncológico Dr. Rosell, Hospital Universitario Dexeus, Barcelona, 08028, Spain.; Germans Trias i Pujol Research Institute (IGTP), Badalona, 08916, Spain., Pease JE; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, CB21 6GH, UK., Polanska UM; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, CB21 6GH, UK., Travers J; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, CB21 6GH, UK., Urosevic J; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, CB21 6GH, UK. jelena.urosevic@astrazeneca.com., Molina-Vila MA; Laboratory of Oncology, Pangaea Oncology, Quiron Dexeus University Hospital, C/ Sabino Arana 5-19, 08913, Barcelona, Spain. mamolina@panoncology.com.
Publikováno v:
Molecular cancer [Mol Cancer] 2023 Jul 13; Vol. 22 (1), pp. 110. Date of Electronic Publication: 2023 Jul 13.
Autor:
Karachaliou N; Instituto Oncológico Dr Rosell, Quiron-Dexeus University Hospital, Barcelona, Spain., Codony-Servat J; Pangaea Biotech, Barcelona, Spain., Teixidó C; Pangaea Biotech, Barcelona, Spain., Pilotto S; Department of Medical Oncology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy., Drozdowskyj A; Pivotal, Madrid, Spain., Codony-Servat C; Pangaea Biotech, Barcelona, Spain., Giménez-Capitán A; Pangaea Biotech, Barcelona, Spain., Molina-Vila MA; Pangaea Biotech, Barcelona, Spain., Bertrán-Alamillo J; Pangaea Biotech, Barcelona, Spain., Gervais R; Centre François Baclesse, Caen, France., Massuti B; Hospital General de Alicante, Alicante, Spain., Morán T; Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Spain., Majem M; Hospital de Sant Pau, Barcelona, Spain., Felip E; Hospital Vall d'Hebron, Barcelona, Spain., Carcereny E; Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Spain., García-Campelo R; Complexo Hospitalario Universitario La Coruña, La Coruña, Spain., Viteri S; Instituto Oncológico Dr Rosell, Quiron-Dexeus University Hospital, Barcelona, Spain., González-Cao M; Instituto Oncológico Dr Rosell, Quiron-Dexeus University Hospital, Barcelona, Spain., Morales-Espinosa D; Instituto Oncológico Dr Rosell, Quiron-Dexeus University Hospital, Barcelona, Spain., Verlicchi A; Ospedale Santa Maria delle Croci, Ravenna, Italy., Crisetti E; Department of Medical and Surgical Sciences, Institute of Respiratory Diseases, University of Foggia, Foggia, Italy., Chaib I; Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Spain., Santarpia M; Human Pathology Department, Medical Oncology Unit, University of Messina, Messina, Italy., Luis Ramírez J; Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Spain., Bosch-Barrera J; Catalan Institute of Oncology, Hospital Josep Trueta, Girona, Spain., Felipe Cardona A; Clinical and Traslational Oncology Group, Institute of Oncology, Clínica del Country, Bogotá, Colombia., de Marinis F; Divisione di Oncologica Toracica, Direttore, Istituto Europeo di Oncologia-IEO, Milano, Italy., López-Vivanco G; Chief, Medical Oncology Service, Hospital de Cruces, Barakaldo, Vizcaya, Spain., Miguel Sánchez J; Medical Oncology Service, Hospital de la Princesa, Madrid, Spain., Vergnenegre A; Hôpital du Cluzeau, Limoges, France., Sánchez Hernández JJ; Unidad de Investigación en Salud Pública CIDICS-UANL, Monterrey, Mexico., Sperduti I; Biostatistics, Regina Elena National Cancer Institute, Rome, Italy., Bria E; Department of Medical Oncology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy., Rosell R; Instituto Oncológico Dr Rosell, Quiron-Dexeus University Hospital, Barcelona, Spain. rrosell@iconcologia.net.; Pangaea Biotech, Barcelona, Spain. rrosell@iconcologia.net.; Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Spain. rrosell@iconcologia.net.; Molecular Oncology Research (MORe) Foundation, Barcelona, Spain. rrosell@iconcologia.net.; Germans Trias i Pujol Health Sciences Institute and Hospital, Campus Can Ruti, Barcelona, Spain. rrosell@iconcologia.net.
Publikováno v:
Scientific reports [Sci Rep] 2023 Mar 03; Vol. 13 (1), pp. 3620. Date of Electronic Publication: 2023 Mar 03.
Autor:
Pedraz-Valdunciel C; Department of Cancer Biology and Precision Medicine, Germans Trias I Pujol Research Institute (IGTP), Campus Can Ruti, 08916 Badalona, Spain.; Department of Biochemistry, Molecular Biology and Biomedicine, Autonomous University of Barcelona, Campus de Bellaterra, 08193 Barcelona, Spain.; Laboratory of Oncology, Pangaea Oncology, Dexeus University Hospital, 08028 Barcelona, Spain., Giannoukakos S; Department of Genetics, Facultad de Ciencias, Campus Fuentenueva s/n, Universidad de Granada, 18071 Granada, Spain., Giménez-Capitán A; Laboratory of Oncology, Pangaea Oncology, Dexeus University Hospital, 08028 Barcelona, Spain., Fortunato D; Exosomics SpA, 53100 Siena, Italy., Filipska M; Department of Cancer Biology and Precision Medicine, Germans Trias I Pujol Research Institute (IGTP), Campus Can Ruti, 08916 Badalona, Spain.; B Cell Biology Group, Hospital del Mar Biomedical Research Park (IMIM), Barcelona Biomedical Research Park (PRBB), 08003 Barcelona, Spain., Bertran-Alamillo J; Laboratory of Oncology, Pangaea Oncology, Dexeus University Hospital, 08028 Barcelona, Spain., Bracht JWP; Vesicle Observation Centre, Laboratory of Experimental Clinical Chemistry, Department of Clinical Chemistry, Amsterdam UMC location University of Amsterdam, 1105AZ Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, 1105AZ Amsterdam, The Netherlands., Drozdowskyj A; Oncology Institute Dr. Rosell (IOR), Dexeus University Institute, 08028 Barcelona, Spain., Valarezo J; Laboratory of Oncology, Pangaea Oncology, Dexeus University Hospital, 08028 Barcelona, Spain., Zarovni N; Exosomics SpA, 53100 Siena, Italy., Fernández-Hilario A; Department of Computer Science and Artificial Intelligence, DaSCI., University of Granada, 18071 Granada, Spain., Hackenberg M; Department of Genetics, Facultad de Ciencias, Campus Fuentenueva s/n, Universidad de Granada, 18071 Granada, Spain., Aguilar-Hernández A; Oncology Institute Dr. Rosell (IOR), Dexeus University Institute, 08028 Barcelona, Spain., Molina-Vila MÁ; Laboratory of Oncology, Pangaea Oncology, Dexeus University Hospital, 08028 Barcelona, Spain., Rosell R; Department of Cancer Biology and Precision Medicine, Germans Trias I Pujol Research Institute (IGTP), Campus Can Ruti, 08916 Badalona, Spain.; Oncology Institute Dr. Rosell (IOR), Dexeus University Institute, 08028 Barcelona, Spain.; Catalan Institute of Oncology, Campus Can Ruti, 08916 Badalona, Spain.
Publikováno v:
Pharmaceutics [Pharmaceutics] 2022 Sep 24; Vol. 14 (10). Date of Electronic Publication: 2022 Sep 24.